Walter E. Aulitzky

Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells

Markus Kleih, Kathrin Böpple, Meng Dong et al. · Cell Death and Disease · 2019 · 410 citations · Full text

Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial

Christoph Röllig, Hubert Serve, Andreas Hüttmann et al. · The Lancet Oncology · 2015 · 395 citations · Full text

Sorafenib Versus Placebo, Hematological Malignancy, Oncology +9

PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group

Peter Borchmann, Helen Goergen, Carsten Kobe et al. · The Lancet · 2017 · 372 citations

Positron Emission Tomography, Advanced-stage Hodgkin, Lymphoid Neoplasia +9

Sorafenib in Combination With Intensive Chemotherapy in Elderly Patients With Acute Myeloid Leukemia: Results From a Randomized, Placebo-Controlled Trial

Hubert Serve, Utz Krug, Ruth Wagner et al. · Journal of Clinical Oncology · 2013 · 309 citations · Full text

Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers

Peter Horak, Christoph Heining, Simon Kreutzfeldt et al. · Cancer Discovery · 2021 · 264 citations